Current research projects

Action for Pulmonary Fibrosis is a leading funder of research into pulmonary fibrosis and idiopathic pulmonary fibrosis. Our support includes direct funding and providing advice through steering groups.

Are you passionate about shaping research into pulmonary fibrosis?

We are calling on you to be pioneers in a truly unique opportunity from the James Lind Alliance to set the priorities for future research.

This is a one-time opportunity for you to shape future research into pulmonary fibrosis across the world. By completing this survey we will ensure that patients, carers, bereaved family members and clinicians are at the heart of pulmonary fibrosis research.

Contribute to the survey

Mike Bray Research Fellowships

Action for Pulmonary Fibrosis is currently funding two research fellowships in honour of APF’s founding chair of trustees Mike Bray, who passed away in 2017. Mike lived for six years following his lung transplant as a result of his IPF.

The recipients are Dr Richard Allen of the University of Leicester and Dr Philip Molyneaux of Imperial College London. The fellowships will end in 2021.

Dr Philip Molyneaux: Microbiome, Metabolism and Macrolides in IPF

In IPF there are changes in the number and types of bacteria in the lungs, but we don’t understand why they are there or what they are doing. Dr Molyneaux’s research will aim to answer these questions, looking at how bacteria interact with cells in the lungs and what changes happen following antibiotics. Understanding this may allow us to identify new treatments or specific groups of patients with IPF who will benefit from existing therapies.

It’s fantastic to be able to undertake research, supported by Action for Pulmonary Fibrosis, a patient-driven charity. I look forward to the next few years of exciting research ahead.

This research is funded by Action for Pulmonary Fibrosis. Help us fund more research like this.

Dr Richard Allen: Investigating the genetics of disease progression and classifying disease subtypes for idiopathic pulmonary fibrosis

This project will compare the DNA of individuals with IPF to identify the genes that explain why some people experience very severe disease whereas others have milder symptoms. This will improve our understanding of IPF and hopefully lead to the development of new treatments which are better targeted to the individuals who are most likely to benefit from them.

I am so excited to be given this chance to extend my work on the genetics of IPF which will help guide the development of new treatments for this devastating disease. I would like to thank Action for Pulmonary Fibrosis for giving me this incredible opportunity.

This research is funded by Action for Pulmonary Fibrosis. Help us fund more research like this.